Creating new medical devices and drugs through collaboration and mentorship
Midwest Biomedical Accelerator Consortium: MBArC
This study is all about helping scientists turn their exciting medical discoveries into real products that can help patients, by teaming up researchers from the University of Missouri and the University of Kansas to share knowledge and resources.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10475264 on NIH RePORTER |
What this research studies
This research aims to enhance the commercialization of biomedical innovations by fostering partnerships between the University of Missouri-Columbia and the University of Kansas Medical Center. It focuses on overcoming barriers that prevent promising laboratory discoveries from reaching the market, such as lack of awareness and insufficient collaboration. By providing mentorship and resources, the project seeks to connect researchers with the necessary expertise to develop and commercialize new medical technologies and treatments. Patients may benefit from the resulting advancements in medical devices and pharmaceuticals that arise from this collaborative effort.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions that could be addressed by new biomedical technologies or therapies developed through this initiative.
Not a fit: Patients who are not affected by conditions that could be treated with new biomedical innovations may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative medical devices and drugs that improve patient care and treatment outcomes.
How similar studies have performed: Other research initiatives focused on academic entrepreneurship and commercialization have shown success in advancing medical technologies, indicating that this approach has potential.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Fay, William P — University of Missouri-Columbia
- Study coordinator: Fay, William P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.